SYRE NASDAQ
Spyre Therapeutics, Inc.
1W: +8.8%
1M: +7.0%
3M: +5.0%
YTD: +204.7%
1Y: +466.2%
3Y: +711.0%
5Y: -51.4%
$93.19
+3.26 (+3.63%)
Weekly Expected Move ±5.3%
$83
$88
$93
$98
$103
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — SYRE
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (11)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 58.3 | 62.4 | 59.6 | 60.1 | SEC ↗ |
| 2026-03-31 | 10-Q | 59.2 | 60.3 | 60.4 | 60.0 | SEC ↗ |
| 2025-12-31 | 10-K | 61.6 | 64.3 | 62.7 | 62.8 | SEC ↗ |
| 2025-09-30 | 10-Q | 57.3 | 61.3 | 60.2 | 59.6 | SEC ↗ |
| 2025-06-30 | 10-Q | 59.3 | 59.7 | 59.4 | 59.5 | SEC ↗ |
| 2025-03-31 | 10-Q | 61.3 | 60.1 | 59.4 | 60.2 | SEC ↗ |
| 2024-12-31 | 10-K | 62.3 | 64.7 | 62.9 | 63.3 | SEC ↗ |
| 2024-09-30 | 10-Q | 60.8 | 62.0 | 62.0 | 61.6 | SEC ↗ |
| 2024-06-30 | 10-Q | 61.1 | 61.0 | 60.7 | 60.9 | SEC ↗ |
| 2024-03-31 | 10-Q | 67.0 | 73.9 | 66.6 | 69.2 | SEC ↗ |
| 2023-12-31 | 10-K/A | 73.0 | 72.8 | 66.3 | 70.7 | SEC ↗ |